Archives: Resources
Real-world evidence studies – Diverse Data Designs
In close collaboration with sponsors, we identify and understand multi-stakeholder evidence needs across the product lifecycle.
US inflation reduction act: pipeline considerations
A risk exposure framework for drug developers.
Navigate the EU HTA Regulation
Trusted partner with 30+ years of experience in EU HTA, aiding health tech developers through EU HTA Regulation complexities.
Registries and Real-world Evidence
Customizable registry solutions for actionable insights, tailored study design, and regulatory-grade data to accelerate development.
Peri- and Post-approval Safety and Real-world Insights
Learn how we optimize post-authorization safety obligations with a holistic, collaborative, and custom study design approach.
Advancing Rare Disease Treatments in the COVID-19 Era and Beyond
Read our white paper on the continued interest in developing treatments for rare diseases.
Pediatric Drug Development: Trends in the EU
A discussion on Pediatric Investigation Plans (PIPs), a 10-year report on the impact of the Regulation, and pediatric clinical trials.
Detailed data analytics improve performance metrics
Clinical care settings rely on teams with many layers functioning at their optimum capacity.